ERBB2 and breast carcinoma: Using the antibody as a template, Shi et al. synthesized an HER-2 peptide analog, sequence YCDGFYACYMDV, which showed increased tumoral delivery of doxorubicin-loaded and pH-sensitive liposomes toward multidrug-resistant MCF-7 breast cancer cells.56